Randall ME, Filiaci VL, Muss H, et al. Gynecologic Oncology Group Study. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma. J Clin Oncol 2006;24:36–44.
308.
Lewis GC Jr, Slack NH, Mortel R, et al. Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer. Gynecol Oncol 1974;2:368–376.
309.
DePalo G, Merson M, Del Vecchio M, et al. A controlled clinical study of adjuvant medroxyprogesterone acetate (MPA) therapy in pathologic stage I endometrial carcinoma with myometrial invasion. Proc Am Soc Clin Oncol 1985;4:121(abst).
310.
Vergote I, Kjorstad J, Abeler V, et al. A randomized trail of adjuvant progestogen in early endometrial cancer. Cancer 1989;64:1011– 1016.
311.
MacDonald RR, Thorogood J, Mason MK. A randomized trial of progestogens in the primary treatment of endometrial carcinoma. BJOG 1988;95:166–174.
312.
COSA-NZ-UK Endometrial Cancer Study Groups. Adjuvant medroxyprogesterone acetate in high-risk endometrial cancer. Int J Gynecol Cancer 1998;8:387–391.
313.
von Minckwitz G, Loibl S, Brunnert K, et al. Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer—a multicentre, open, controlled, prospectively randomized trial. Eur J Cancer 2002;38:2265–2271.
314.
Morrow CP, Bundy B, Homesley H, et al. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II. Gynecol Oncol 1990;36:166–171.
315.
Randall ME, Brunetto G, Muss H, et al. Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: a randomized phase III trial of the Gynecologic Oncology Group. Proc Am Soc Clin Oncol 2003;22:abstr 3.
316.
Hogberg T, Signorelli M, de Oliveira CF, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer: results from two randomised studies. Eur J Cancer 2010;46:2422–2431.
317.
Susumu N, Sagae S, Udagawa Y, et al. Japanese Gynecologic Oncology Group. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate-and high-risk endometrial cancer. Gynecol Oncol 2008;108:226–233.
318.
Homesley HD, Boronow RC, Lewis JL Jr. Stage II endometrial adenocarcinoma: Memorial Hospital for Cancer, 1949–1965. Obstet Gynecol 1977;49:604–608.
319.
Surwit EA, Fowler WC Jr, Rogoff EE, et al. Stage II carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 1979;5:323–326.
320.